Literature DB >> 8542163

The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis.

R Jörres1, D Nowak, H Magnussen.   

Abstract

The aim of this study was to determine whether ozone enhances bronchial responsiveness to allergens in subjects with allergic asthma, or facilitates a bronchial response in subjects with allergic rhinitis. Twenty-four subjects with mild stable allergic asthma, 12 subjects with allergic rhinitis without asthma, and 10 healthy subjects participated in the study. Subjects breathed 250 ppb ozone or filtered air (FA) for 3 h of intermittent exercise. Airway responsiveness to methacholine was determined 1 h before and after exposures, and allergen responsiveness 3 h after exposures. We determined the concentration of methacholine (PC20FEV1) and the dose of allergen (PD20FEV1) producing a 20% fall in FEV1. In the subjects with asthma, FEV1 decreased by 12.5 +/- 2.2% (mean +/- SEM; p = 0.0001), PC20FEV1 of methacholine by 0.91 +/- 0.19 doubling concentrations (p = 0.0001) and PD20FEV1 of allergen by 1.74 +/- 0.25 doubling doses (p < 0.0001) after ozone compared with FA. The changes in lung function, methacholine, and allergen responsiveness did not correlate with each other. In the subjects with rhinitis, mean FEV1 decreased by 7.8% and 1.3% when ozone or FA, respectively, were followed by allergen inhalation (p = 0.035). Therefore, our data suggest that short-term exposure to ozone can increase bronchial allergen responsiveness in subjects with mild allergic asthma or rhinitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542163     DOI: 10.1164/ajrccm.153.1.8542163

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

1.  Ozone differentially modulates airway responsiveness in atopic versus nonatopic guinea pigs.

Authors:  Richard B Schlesinger; Mitchell D Cohen; Terry Gordon; Christine Nadziejko; Judith T Zelikoff; Maureen Sisco; Jean F Regal; Margaret G Ménache
Journal:  Inhal Toxicol       Date:  2002-05       Impact factor: 2.724

2.  Fungal and other spore counts as predictors of admissions for asthma in the Trent region.

Authors:  R Newson; D Strachan; J Corden; W Millington
Journal:  Occup Environ Med       Date:  2000-11       Impact factor: 4.402

Review 3.  Oxidative stress in the pathogenesis of asthma.

Authors:  Russell P Bowler
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

Review 4.  Ozone and pulmonary innate immunity.

Authors:  John W Hollingsworth; Steven R Kleeberger; W Michael Foster
Journal:  Proc Am Thorac Soc       Date:  2007-07

Review 5.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 6.  Climate change. A global threat to cardiopulmonary health.

Authors:  Mary B Rice; George D Thurston; John R Balmes; Kent E Pinkerton
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

7.  [Recommendations for implementing bronchial provocation tests with pharmacologic substances. German Society of Pneumology--Scientific "Bronchial Provocation Tests" Study Group].

Authors:  G Klein
Journal:  Med Klin (Munich)       Date:  1997-08-15

Review 8.  Environment, Global Climate Change, and Cardiopulmonary Health.

Authors:  Hasan Bayram; Alison K Bauer; Waleed Abdalati; Christopher Carlsten; Kent E Pinkerton; George D Thurston; John R Balmes; Tim K Takaro
Journal:  Am J Respir Crit Care Med       Date:  2017-03-15       Impact factor: 21.405

Review 9.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

10.  Effect of nitrogen dioxide and ozone on the risk of dying in patients with severe asthma.

Authors:  J Sunyer; X Basagaña; J Belmonte; J M Antó
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.